0.2780EUR-1.07%Mkt Cap: 14.28M $P/E: 13.90Today
Celyad Oncology SA, a biotechnology company, focuses on unlocking the potential of its intellectual property. Its portfolio comprises multiple foundational US patents focused on TCR-deficient T cell compositions, and it…
Industry Peers
Biotechnology$130.23BUSDP/E 32.1
$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$61.34BUSDP/E 39.8
$45.95BUSDP/E 19.6
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.26BUSDP/E 26.6
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
Key Statistics
Company
Market Cap14.28M $
Enterprise Value11.82M $
Revenue (TTM)22.83K $
Gross Profit14.13K $
Net Income (TTM)902.17K $
Revenue/Share0.0000 USD
Last Price0.2780 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees4
CountryBE
SectorHealthcare
IndustryBiotechnology
ISINBE0974260896
Valuation
P/E (Trailing)13.90
P/E (Forward)0.44
PEG—
EV/EBITDA-7.15
EV/Revenue517.62
P/S632.41
P/B5.20
EPS (TTM)0.02
EPS (Forward)0.64
52W Range
0.160024% of range0.6500
52W High0.6500 EUR
52W Low0.1600 EUR
Profitability
Gross Margin61.90%
Oper. Margin30414.28%
EBITDA Margin0.00%
Profit Margin3952.38%
ROE34.06%
ROA19.31%
Growth
Revenue Growth-95.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-7.50M $
CapEx (TTM)—
FCF Margin-5038.69%
FCF Yield-8.05%
Net Debt-1.86M $
Net Debt/EBITDA1.12
Balance Sheet
Debt/Equity0.00
Current Ratio1.92
Quick Ratio1.38
Book Value/Sh0.0540 EUR
Cash/Share0.0380 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.47.26M
Float14.15M
Insiders10.28%
Institutions55.49%
Technical
SMA 500.2578 (+7.8%)
SMA 2000.2618 (+6.2%)
Beta1.21
S&P 52W Chg18.16%
Avg Vol (30d)18.20K
Avg Vol (10d)13.40K
Technical Indicators
RSI (14)55.1
MACD0.0049
MACD Signal0.0033
MACD Hist.+0.0016
BB Upper0.2963 EUR
BB Middle0.2712 EUR
BB Lower0.2461 EUR
BB Width18.49%
ATR (14)0.0232 EUR
Vol Ratio (20d)2.03x